We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Canadian Regulators to Crack Down On Generic Pay-for-Delay Deals
Canadian Regulators to Crack Down On Generic Pay-for-Delay Deals
Canadian regulators plan to ratchet up scrutiny of patent litigation settlements between brand and generic drugmakers in search of antitrust deals that delay generic competition.